The rate of curative intended therapy against recurrent lung cancer before and after introduction of a CT-based follow-up program

N. C. G. Hansen (Odense, Denmark)

Source: Annual Congress 2013 –Quality management in thoracic oncology
Session: Quality management in thoracic oncology
Session type: Oral Presentation
Number: 4828
Disease area: Thoracic oncology

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. C. G. Hansen (Odense, Denmark). The rate of curative intended therapy against recurrent lung cancer before and after introduction of a CT-based follow-up program. Eur Respir J 2013; 42: Suppl. 57, 4828

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Influence of neoadjuvant therapy to complication rate after surgery for primary lung cancer
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016

Efficacy of preoperative comprehensive pulmonary rehabilitation in patients with lung cancer
Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases
Year: 2016

Completion pneumonectomy for lung cancer relapse after surgery- What is a real benefit?
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013


Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016

Surgical treatment outcomes on early-stages of non-small-cell lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015


Characteristics of smoking behaviour in patients post-curative resection of stage 1 lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015

Gene therapy with DDMC-p53 with or without cisplatin and microwave ablation. A future concept for local treatment in lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015

Sleeve lung resection for non-small cell lung cancer after induction therapy: A safe method
Source: International Congress 2016 – Special issues in thoracic surgery
Year: 2016


Smoking at the time of curative-intent lung cancer surgery dramatically influences peri-operative complications
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015

Mode of influence of the type of the chest wall invasion to the outcome of surgical treatment of patients with primary lung cancer
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015

Preliminary efficacy of preoperative exercise training in patients with lung malignancies undergoing VATS
Source: International Congress 2016 – Effects of exercise training interventions in chronic respiratory disease
Year: 2016

Contribution of adjuvant chemotherapy in stage I pulmonary adenocarcinoma after surgical resection
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016

Completion pneumonectomy for lung cancer relapse after surgery- What is a real benefit?
Source: International Congress 2016 – Special issues in thoracic surgery
Year: 2016

Physiological predictors of mortality in high-risk patients undergoing surgery for lung cancer
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016


The risk of recurrence after intraoperative needle biopsy(INB) for preoperative undiagnosed early stage lung cancers
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014

Outcomes of radical treatment of early stage non-small cell lung cancer
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015


Symptom occurrence in lung cancer patients prior to surgery
Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education
Year: 2013


Stereotactic ablative radiotherapy (SABR) in non-surgical non small cell lung cancer: Effects on respiratory function
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014


Pulmonary function during lung cancer therapy: A retrospective analysis of patients treated with monotherapy or multimodal treatments
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016

Maintenance therapy with pemetrexed in non-small-cell lung cancer: Impact on survival
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015